KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs Oct 12, 2022 7:01am EDT
KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium Oct 05, 2022 7:01am EDT
KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference Aug 04, 2022 4:01pm EDT
KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022 Jul 20, 2022 4:01pm EDT
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge® May 02, 2022 4:01pm EDT
KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022 Apr 20, 2022 4:01pm EDT
